Levocarnitine induced seizures in patients on valproic acid
Spacing these products apart may be recommended
As GLP-1 receptor agonists have become one of the most widely prescribed drug classes in the United States for weight loss and type 2 diabetes, hair loss has emerged as a real, documented, and increasingly common concern among patients in Newport Beach, Orange County, Los Angeles, and across California
An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)
Leukemia & Lymphoma
This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, gas, hair loss, GERD, abdominal distension, dizziness, and low blood pressure